John Sprague

Track

Insider profile

Currently holds a position at T2 Biosystems Inc

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -19% 8.2% 15.1%
Success rate 42% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer T2 Biosystems Inc Feb. 5, 2018 -
John Sprague's trades of T2 Biosystems Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
26.35
Quantity 23,306 +48.1%
Value US$1,995,155
Transaction date
Planned sale
Price
232.36
Quantity 87,781 +16.9%
Value US$2,285,744
Transaction date
Purchase
Price
109.22
Quantity 69,837 -10.7%
Value US$218,099
Transaction date
Planned sale
Price
2.04
Quantity 5,250 -12.9%
Value US$10,710
Transaction date
Sale
Price
0.82
Quantity 4,166 -15.8%
Value US$3,416
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-09 2023-02-28
PlS Planned sale
23,306 +48.1%
26.35
US$1,995,155 		23,306 +48.1% 26.35 US$1,995,155
2023-03-09 2023-02-22
PlS Planned sale
87,781 +16.9%
232.36
US$2,285,744 		87,781 +16.9% 232.36 US$2,285,744
2022-04-11 2022-04-08
B Purchase
69,837 -10.7%
109.22
US$218,099 		69,837 -10.7% 109.22 US$218,099
2021-02-23 2021-02-23
PlS Planned sale
5,250 -12.9%
2.04
US$10,710 		5,250 -12.9% 2.04 US$10,710
2020-03-03 2020-02-24
S Sale
4,166 -15.8%
0.82
US$3,416 		4,166 -15.8% 0.82 US$3,416